- Home
- MD vs SYRE Comparison
MD vs SYRE Comparison
Compare MD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MD
- SYRE
- Stock Information
- Founded
- MD 1979
- SYRE 2013
- Country
- MD United States
- SYRE United States
- Employees
- MD N/A
- SYRE N/A
- Industry
- MD Hospital/Nursing Management
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- MD Health Care
- SYRE Health Care
- Exchange
- MD Nasdaq
- SYRE Nasdaq
- Market Cap
- MD 1.2B
- SYRE 1.1B
- IPO Year
- MD 1995
- SYRE 2016
- Fundamental
- Price
- MD $16.15
- SYRE $16.78
- Analyst Decision
- MD Buy
- SYRE Buy
- Analyst Count
- MD 6
- SYRE 5
- Target Price
- MD $16.75
- SYRE $55.00
- AVG Volume (30 Days)
- MD 841.7K
- SYRE 498.2K
- Earning Date
- MD 08-05-2025
- SYRE 08-05-2025
- Dividend Yield
- MD N/A
- SYRE N/A
- EPS Growth
- MD N/A
- SYRE N/A
- EPS
- MD 1.29
- SYRE N/A
- Revenue
- MD $1,940,725,000.00
- SYRE N/A
- Revenue This Year
- MD N/A
- SYRE N/A
- Revenue Next Year
- MD $3.26
- SYRE N/A
- P/E Ratio
- MD $12.49
- SYRE N/A
- Revenue Growth
- MD N/A
- SYRE N/A
- 52 Week Low
- MD $10.06
- SYRE $10.91
- 52 Week High
- MD $17.67
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- MD 71.37
- SYRE 52.95
- Support Level
- MD $14.05
- SYRE $15.73
- Resistance Level
- MD $16.98
- SYRE $17.42
- Average True Range (ATR)
- MD 0.61
- SYRE 0.91
- MACD
- MD 0.27
- SYRE 0.02
- Stochastic Oscillator
- MD 83.66
- SYRE 76.29
About MD Pediatrix Medical Group Inc.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.